Opinion · 116th Congress
Drug pricing is secretive. Fix that first
One result is that the average net price of a brand-name specialty drug in Part D grew at an annual rate of 22 percent from 2010 to 2015, while 25 percent of Part D spending applied to fewer than 1 percent